The Bioanalysis CRO Selection Checklist Every Sponsor Should Use Before Signing An MSA

Choosing a bioanalysis CRO often appears straightforward, but polished presentations and competitive pricing rarely reveal how a lab actually performs once a study begins. A sound selection process requires more than reviewing capabilities decks — it demands a structured evaluation of the operational realities that determine whether data will arrive on time, withstand regulatory scrutiny, and support critical program decisions.

A thorough checklist helps teams look past headline metrics and probe the infrastructure behind them. That means understanding what a quoted turnaround time really includes, how much of the workflow is automated versus manual, and whether GLP compliance is supported by an independent QAU and validated electronic systems. Scientific depth is equally important; sponsors need direct access to the experts running their assays, not just business development contacts. Pricing transparency, communication habits, and true capacity also signal how a CRO will perform once timelines tighten and unexpected results surface.

This framework gives sponsors a way to differentiate between vendors that can run an assay and partners equipped to support development responsibly. Using it before signing an MSA helps teams avoid downstream surprises and build relationships grounded in operational clarity rather than assumptions.